MRI-guided biopsy or treatment using a perineal grid approach
Part of Kidney & urinary clinical trials.
This study looks at a new way to do an MRI-guided prostate biopsy or ablation using a small “grid” approach through the area between the scrotum and anus. It may help doctors target suspicious spots on MRI more precisely while keeping the procedure safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for an MRI-guided biopsy or an MRI-guided ablation (a treatment that targets tissue).
- Your MRI shows 1 to 3 suspicious tumor areas that doctors want to target.
- You can safely receive anesthesia or sedation for the procedure.
- You can understand the study and sign informed consent.
- You do not have any metal or other materials in your body that cannot be scanned safely by MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment where doctors use MRI pictures to guide freezing of a prostate tumor. It may help men with smaller, well-placed prostate cancers who cannot or do not want surgery or radiation right now.
This trial tests a newer way to treat certain low- to intermediate-risk prostate cancers using MRI guidance and an ultrasound probe placed through the urethra. It aims to destroy the tumor while using imaging to help target it more precisely.
This study tests whether using MRI imaging to guide prostate biopsies can help doctors sample only suspicious areas instead of taking many samples throughout the prostate. It may reduce discomfort and complications while still finding prostate cancer if present.
This trial tests whether a special type of radiation therapy, guided by MRI, can treat prostate cancer with fewer side effects. The treatment is given in a highly precise way to target the cancer while sparing healthy tissue.
This trial uses MRI to guide a biopsy of the prostate, aiming to better detect cancer in men with abnormal PSA levels, a lump, or a suspicious MRI finding.
This trial tests if using MRI and a blood test called PHI can help decide who needs a prostate biopsy. It aims to avoid unnecessary biopsies while still catching cancer early.
Hear when a new Prostate Biopsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.